Neuroprotective effect of acteoside against rotenone-induced damage of SH-SY5Y cells and its possible mechanism

Chinese Pharmacological Bulletin

Volumn 23, Issue 2, 2007, Pages 161-165

  Gao, Yan ^a   Pu, Xiao Ping ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Acteoside; Lactate dehydrogenase (LDH); Parkin; Rotenone; SH SY5Y cells; Syn

Indexed keywords

ACTEOSIDE; ALPHA SYNUCLEIN; LACTATE DEHYDROGENASE; PARKIN; ROTENONE;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NEUROBLASTOMA CELL; NEUROPROTECTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

EID: 34247505547     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Burch D, Sheerin F. Parkinson disease[J]. Lancet, 2005,365(9459):622-7.
2. Cookson M R. The biochemistry of Parkinson disease[J]. Ann Rev Biochem, 2005,74:29-52.
3. Ali Samii, John G Nt, Bruce R R. Parkinson disease[J]. The Lancet, 2004,363(9423):1783-93.
4. Staropoli J F, McDermott C, Martinat C, et al. Parkin is a component of an SCF-like ubiquitin ligase complex and protects post mitotic neurons from kainate excitotoxicity[J]. Neuron, 2003,37(5):735-49.
5. Feany M B, Bender W W. A Drosophila model of Parkinson disease[J]. Nature, 2000,404,394-8.
6. Yang F Y, Pu X P. Protective effect of acteoside on SH-SY5Y cells apoptosis induced by rotenone and the mechanism[J]. Chin Pharmacol Bull, 2006,22(2):159-64.
7. Xiong Q, Tezuka Y, Kaneko T, et al. Inhibition of nitric oxide by phenylethanoids in activater macrophages[J]. Eur J Pharmacol, 2000,400:137-44.
8. Sheng G Q, Zhang J R, Pu X P, et al. Protection effect of verbascoside on 1-methyl-4-phenyl-pyridini-um ion-induced neurotoxicity in PC12 cells[J]. Eur J Pharmacol, 2002,451(2):119-24.
9. Wang L Z, Zhu X Z. The development of molecular mechanism study of Parkinson disease[J]. Chin Pharmacol Bull, 2004,20(10):1081-5.
10. Imai Y, Soda M, Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity[J]. J Bio Chem, 2000,275(46):35661-4.
11. Petrucelli L, O'Farrell C, Lockhart P J, et al. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfuction selectively affects cate-cholaminergic neurons[J]. Neuron, 2002,36(6):1007-19.
12. Bence N F, Sampat R M, Kopito R R, et al. Impairment of the ubiquitin proteasome system by protein aggregation[J]. Science, 2001,292:1552-5.
13. Morett E, Bork P. A novel transactivation domain in parkin[J]. Trends Biochem Sci, 1999,24:229-31.